Initiating HCP-Patient Conversations on Symptoms in UC Initiating HCP-Patient Conversations on Symptoms in UC
Watch experts Aline Charabaty, Raja Atreya, and Axel Dignass reveal how they initiate conversations on symptoms with patients suffering from ulcerative colitis.Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 5, 2023 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news

Statins linked to lower risk of colorectal cancer in patients with ulcerative colitis
Cholesterol-lowering statins might protect patients with ulcerative colitis from developing and dying from colorectal cancer. Statin treatment was also associated with a lower risk of death regardless of cause in patients with ulcerative colitis or Crohn's disease. This is according to a study by researchers at Karolinska Institutet in Sweden published in eClinicalMedicine. (Source: World Pharma News)
Source: World Pharma News - September 1, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Excerpt: Rethinking Treatment Targets with Dr. David T. Rubin Excerpt: Rethinking Treatment Targets with Dr. David T. Rubin
Watch this short video to find out why we should update current definitions of clinical remission in ulcerative colitis to include bowel urgency and histologic remission.Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 30, 2023 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news

Vedolizumab vs. Anti-TNF Agents in Biologic-naive UC Patients Vedolizumab vs. Anti-TNF Agents in Biologic-naive UC Patients
This study investigated the effectiveness of vedolizumab versus anti-TNF therapy in biologic-naive patients with ulcerative colitis at the end of induction therapy and during maintenance treatment.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 29, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

The Establishment Failed Pel é And Kristie
I was saddened to hear that soccer legend Pelé and “Cheers” star Kirstie Alley both died of colon cancer late last year. But the wider part of this tragedy is that this kind of cancer is highly preventable and still poorly understood by most doctors. Mainstream physicians – as well as the media – will tell you your age causes colon cancer, the genes you inherited from your family, and a high-fat diet. They couldn’t be more wrong. Colorectal cancer has nothing to do with age and very little to do with your genes… Instead, it has everything to do with epigenetics. This is the important relationship between o...
Source: Al Sears, MD Natural Remedies - August 25, 2023 Category: Complementary Medicine Authors: Jacob Tags: Cancer Source Type: news

Biologics After Exposure to TNF Inhibitors in Ulcerative Colitis Biologics After Exposure to TNF Inhibitors in Ulcerative Colitis
This study assessed the real-world efficacy of vedolizumab, ustekinumab and tofacitinib as second-line therapies in patients with ulcerative colitis who were previously exposed to a TNF inhibitor.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 8, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

New Horizons in the Management of Ulcerative Colitis New Horizons in the Management of Ulcerative Colitis
Watch this in-depth masterclass to learn more about the management of ulcerative colitis in Middle Eastern countries, and to get an update on novel treatment options and recent clinical data.Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 2, 2023 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news

Rethinking Goal Definitions with Dr. David T. Rubin Rethinking Goal Definitions with Dr. David T. Rubin
Why should we rethink treatment goals in ulcerative colitis to encompass targets like histologic activity and bowel urgency? Watch this lecture to find out more.Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 31, 2023 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news

Playing Through the Pain of Ulcerative Colitis
Two-time Olympian and former professional soccer player Rosie White shares how she overcame ulcerative colitis on and off the field. (Source: WebMD Health)
Source: WebMD Health - July 28, 2023 Category: Consumer Health News Source Type: news

New Drug Could Boost Outcomes for People With Ulcerative Colitis
TUESDAY, July 18, 2023 -- People living with the pain, bloody diarrhea and sometimes urgent need to use the toilet that comes with ulcerative colitis may soon have a new treatment option that ’s already been given the go-ahead in Europe. The drug... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 18, 2023 Category: General Medicine Source Type: news

New Drug Awaiting FDA Approval, Omvoh, Could Boost Outcomes for People With Ulcerative Colitis
TUESDAY, July 18, 2023 -- People living with the pain, bloody diarrhea and sometimes urgent need to use the toilet that comes with ulcerative colitis may soon have a new treatment option that’s already been given the go-ahead in Europe. The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 18, 2023 Category: General Medicine Source Type: news

Mirikizumab for UC: Phase 3 Data Now Published in NEJM Mirikizumab for UC: Phase 3 Data Now Published in NEJM
Mirikizumab manufacturer Eli Lilly, which funded the study, is hoping the drug will become the first IL-23 inhibitor to be approved in the United States for the treatment of ulcerative colitis (UC).MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 13, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

‘ Forever Chemical ’ Lawsuits Could Ultimately Eclipse the Big Tobacco Settlement
It was the dead cows on Wilbur Tennant’s farm that shaped most of Rob Bilott’s professional life. Tennant’s farm was located in Parkersburg, W. Va.; Bilott was—and remains—an environmental lawyer at the firm of Taft Stettinius & Hollister in Cincinnati. All had been well for Tennant until 1998, when half of his herd of 300 cows began to languish and die. The farmer and the lawyer never would have come together, but Bilott’s grandmother lived near Tennant, and a mutual friend suggested Tennant call her grandson for counsel. Tennant had reason to suspect he needed the help of an envir...
Source: TIME: Science - July 12, 2023 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized Environment healthscienceclimate Source Type: news

Aurobindo Pharma subsidiary enters pact with BioFactura for biosimilar ustekinumab
CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma said it has entered into an exclusive license agreement with the US-based BioFactura to commercialize BFI-751, a proposed biosimilar to Stelara (ustekinumab). Ustekinumab is used for treating Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 10, 2023 Category: Pharmaceuticals Source Type: news

Mirikizumab Tops Placebo for Moderately-to-Severely Active Ulcerative Colitis
FRIDAY, July 7, 2023 -- For patients with moderately-to-severely active ulcerative colitis, mirikizumab is more effective than placebo for inducing and maintaining clinical remission, according to a study published in the June 29 issue of the New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 7, 2023 Category: Pharmaceuticals Source Type: news